You are here

News

11/13/2017

Duke University Medical Center has received permission from the FDA to offer cord blood therapy for conditions like autism spectrum disorder and cerebral palsy under an expanded access clinical trial. This expanded access means that children worldwide who have acquired neurologic conditions can have access to cord blood therapy regardless of whether they qualify for a targeted clinical trial. The only restriction is that they must have their own cord blood or a matching sibling's cord blood in storage, most likely in a family cord blood bank.

Read more...
10/31/2017

The number of clinical trials that work with placental cells and tissue exceeds the number that can be found by searching on the keyword "placenta".  Dozens of clinical trials use the placenta but do not contain the keyword "placenta". But, out of hundreds of clinical trials that use the placenta, we find that only 4% are conducting advanced cell therapy.

Read more...
10/02/2017

Now that the mid-point of 2017 has passed, we can give a brief update on the growth rate of advanced cell therapy from 2016 to 2017. The number of trials registered worldwide was 582 for all of 2016 and 315 for the first half of 2017, a modest 8% increase in the average number of trials per month.

Read more...
09/06/2017

Our latest featured trial is NCT03015623, which was registered in January 2017 but started recruiting patients in June 2017. In this trial, patients with acute kidney injury have their blood filtered through a device that holds mesenchymal stem/stromal cells from allogeneic bone marrow.

Read more...
04/12/2017

Duke University is the first academic center in the west to register a Phase 1 trial testing MSC infusions as therapy for autism. The MSC product will be isolated from umbilical cord tissue by enzymatic digestion, expanded in culture, and cryopreserved.

Read more...
03/27/2017

Registered in February 2017, this trial is a phase 1/2 study that compares bone marrow MSC versus umbilical cord tissue MSC for the treatment of chronic inflammation due to metabolic syndrome.

Read more...
03/07/2017

Our team checked each of the 209 entries in ClinicalTrials.gov that are supposedly open cord blood trials, and found that only 118 of these trials are conducting cell therapy with cord blood. This analysis took weeks of effort, but in the end revealed that for the exact phrase “cord blood”, only 56% of open trials found by keyword hits are active cell therapy trials.

Read more...